SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape.
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape.
复制标题
DOI:
10.1016/j.chom.2022.01.005
复制
发表时间:
2022-02-09
影响因子:
30.3
通讯作者:
Sigal A
中科院分区:
文献类型:
--
作者:
Cele S;Karim F;Lustig G;San JE;Hermanus T;Tegally H;Snyman J;Moyo-Gwete T;Wilkinson E;Bernstein M;Khan K;Hwa SH;Tilles SW;Singh L;Giandhari J;Mthabela N;Mazibuko M;Ganga Y;Gosnell BI;Karim SSA;Hanekom W;Van Voorhis WC;Ndung'u T;COMMIT-KZN Team;Lessells RJ;Moore PL;Moosa MS;de Oliveira T;Sigal A
Characterizing SARS-CoV-2 evolution in specific geographies may help predict properties of the variants that come from these regions. We mapped neutralization of a SARS-CoV-2 strain that evolved over 6 months from ancestral virus in a person with advanced HIV disease in South Africa; this person was infected prior to emergence of the Beta and Delta variants. We longitudinally tracked the evolved virus and tested it against self-plasma and convalescent plasma from ancestral, Beta, and Delta infections. Early virus was similar to ancestral, but it evolved a multitude of mutations found in Omicron and other variants. It showed substantial but incomplete Pfizer BNT162b2 escape, weak neutralization by self-plasma, and despite pre-dating Delta, it also showed extensive escape of Delta infection-elicited neutralization. This example is consistent with the notion that SARS-CoV-2 evolving in individual immune-compromised hosts, including those with advanced HIV disease, may gain immune escape of vaccines and enhanced escape of Delta immunity, and this has implications for vaccine breakthrough and reinfections. An ancestral SARS-CoV-2 infection that persisted over 6 months evolved neutralization escape Evolved virus serological relationship is mapped to ancestral virus and key variants Evolved virus shows greatest escape from Delta-elicited immunity and least from Beta-elicited immunity Evolved virus substantially but incompletely escapes BNT162b2 vaccine-elicited antibodies Cele et al. examine a SARS-CoV-2 infection persisting over 6 months, starting as ancestral virus but evolving various mutations found in Omicron and other variants. The evolved virus substantially but incompletely escaped BNT162b2-elicited immunity as well as neutralization by self-plasma and showed extensive escape from neutralization elicited by Delta infections.
登录
查看更多内容
影响因子:
16.6
作者:
Greaney AJ;Starr TN;Barnes CO;Weisblum Y;Schmidt F;Caskey M;Gaebler C;Cho A;Agudelo M;Finkin S;Wang Z;Poston D;Muecksch F;Hatziioannou T;Bieniasz PD;Robbiani DF;Nussenzweig MC;Bjorkman PJ;Bloom JD
通讯作者:
Bloom JD
影响因子:
4.8
作者:
Chen L;Zody MC;Di Germanio C;Martinelli R;Mediavilla JR;Cunningham MH;Composto K;Chow KF;Kordalewska M;Corvelo A;Oschwald DM;Fennessey S;Zetkulic M;Dar S;Kramer Y;Mathema B;Germer S;Stone M;Simmons G;Busch MP;Maniatis T;Perlin DS;Kreiswirth BN
通讯作者:
Kreiswirth BN
影响因子:
64.8
作者:
Barnes CO;Jette CA;Abernathy ME;Dam KA;Esswein SR;Gristick HB;Malyutin AG;Sharaf NG;Huey-Tubman KE;Lee YE;Robbiani DF;Nussenzweig MC;West AP Jr;Bjorkman PJ
通讯作者:
Bjorkman PJ
影响因子:
64.5
作者:
Garcia-Beltran, Wilfredo F.;Lam, Evan C.;Balazs, Alejandro B.
通讯作者:
Balazs, Alejandro B.
影响因子:
11.8
作者:
Guzman MG;Alvarez M;Rodriguez-Roche R;Bernardo L;Montes T;Vazquez S;Morier L;Alvarez A;Gould EA;Kouri G;Halstead SB
通讯作者:
Halstead SB